Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2002

Conditions
HIV Infections
Interventions
DRUG

Enfuvirtide

Trial Locations (25)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10029

Metropolitan Hosp Ctr, New York

10037

Harlem Hosp Ctr, New York

10457

Bronx Lebanon Hosp Ctr, The Bronx

10461

Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx

11021

North Shore Univ Hosp, Great Neck

13210

SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse

20060

Howard Univ Hosp, Washington D.C.

32209

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville

33161

Univ of Miami (Pediatric), Miami

48201

Children's Hosp of Michigan, Detroit

90801

Long Beach Memorial (Pediatric), Long Beach

200102916

Children's Hosp of Washington DC, Washington D.C.

277103499

Duke Univ Med Ctr, Durham

294253312

Med Univ of South Carolina, Charleston

701122699

Tulane Univ / Charity Hosp of New Orleans, New Orleans

900276016

Children's Hosp of Los Angeles/UCLA Med Ctr, Los Angeles

920930672

UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla

941430105

UCSF / Moffitt Hosp - Pediatric, San Francisco

021155724

Children's Hosp of Boston, Boston

02118

Boston City Hosp / Pediatrics, Boston

01199

Baystate Med Ctr of Springfield, Springfield

016550001

Univ of Massachusetts Med School, Worcester

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

009367344

San Juan City Hosp, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH